Literature DB >> 15183626

Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1).

Brunangelo Falini1, Enrico Tiacci, Arcangelo Liso, Katia Basso, Elena Sabattini, Roberta Pacini, Robin Foa, Alessandro Pulsoni, Riccardo Dalla Favera, Stefano Pileri.   

Abstract

A marker capable of distinguishing with certainty between hairy cell leukaemia and other B-cell malignant disease would be of great diagnostic value. Through gene expression profiling, annexin A1 (ANXA1) has been identified as a gene that is upregulated in hairy cell leukaemia. We did immunostaining of 500 B-cell tumours with a specific anti-ANXA1 monoclonal antibody and showed that ANXA1 protein expression is specific to hairy cell leukaemia. Immunocytochemical detection of ANXA1 represents a simple, inexpensive, highly sensitive and specific (100%) assay for diagnosis of hairy cell leukaemia. This assay will be especially useful in distinguishing hairy cell leukaemia from splenic lymphoma with villous lymphocytes and variant hairy cell leukaemia, both of which usually respond poorly to treatments that are effective in hairy cell leukaemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183626     DOI: 10.1016/S0140-6736(04)16356-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  42 in total

1.  Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.

Authors:  Liqiang Xi; Evgeny Arons; Winnifred Navarro; Katherine R Calvo; Maryalice Stetler-Stevenson; Mark Raffeld; Robert J Kreitman
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

2.  Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features.

Authors:  George Kanellis; Manuela Mollejo; Santiago Montes-Moreno; Socorro-María Rodriguez-Pinilla; Juan C Cigudosa; Patricia Algara; Carlos Montalban; Estella Matutes; Andrew Wotherspoon; Miguel A Piris
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

3.  Annexin 1 and its evolving role in systemic carcinogenesis besides its role in the pathogenesis of breast carcinomas.

Authors:  Shailendra Kapoor
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

4.  Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation.

Authors:  Frederic Peyrade; Daniel Re; Clemence Ginet; Lauris Gastaud; Maryline Allegra; Robert Ballotti; Antoine Thyss; Thorsten Zenz; Patrick Auberger; Guillaume Robert
Journal:  Haematologica       Date:  2013-01-08       Impact factor: 9.941

Review 5.  Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.

Authors:  Scott D Boyd; Yasodha Natkunam; John R Allen; Roger A Warnke
Journal:  Appl Immunohistochem Mol Morphol       Date:  2013-03

6.  Monoclonal antibody HBME-1 reacts with a minor subset of B cells with villous surface and can be useful in the diagnosis of hairy cell leukemia and other indolent lymphoproliferations of villous B lymphocytes.

Authors:  László Krenács; Judit Tóth-Lipták; Judit Demeter; Klára Piukovics; Zita Borbényi; Péter Gogolák; Eszter Sári; Enikő Bagdi
Journal:  Virchows Arch       Date:  2013-10-05       Impact factor: 4.064

Review 7.  Differential network analysis in human cancer research.

Authors:  Ryan Gill; Somnath Datta; Susmita Datta
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 8.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

9.  Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.

Authors:  Haipeng Shao; Katherine R Calvo; Marlene Grönborg; Prashant R Tembhare; Robert J Kreitman; Maryalice Stetler-Stevenson; Constance M Yuan
Journal:  Leuk Res       Date:  2013-01-22       Impact factor: 3.156

10.  Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.

Authors:  Enrico Tiacci; Gianluca Schiavoni; Maria Paola Martelli; Emanuela Boveri; Roberta Pacini; Alessia Tabarrini; Silvia Zibellini; Alessia Santi; Valentina Pettirossi; Elisabetta Fortini; Stefano Ascani; Luca Arcaini; Giorgio Inghirami; Marco Paulli; Brunangelo Falini
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.